Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

SERBORDISINN

Financiado

Cerrado

Strengthening the Research Potential of IMGGE through Reinforcement of Biomedica...

Strengthening the Research Potential of IMGGE through Reinforcement of Biomedical Science of Rare Diseases in Serbia en route for innovation SERBORDISinn will enable IMGGE to become the most recognizable molecular genetic (MG) centre in the Balkans. IMGGE is the leading Serbian MG research institution, employing scientists with the highest expertise in molecular biolog... ver más

30/06/2016

IMGGE

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

INSTITUT ZA MOLEKULARNU GENETIKU I GENETICKO... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2016-06-30 No tenemos la información de la convocatoria

0% 90% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

IMGGE

0.00€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

BIOSTRENGTH Strengthening Regional Bioresearch Potential in Greece Adva... 1M€ Cerrado

BRIDGING-RD BRIDGing the research and INnovation Gap for Rare Diseases i... 1M€ Cerrado

SAF2015-69146-REDC RED DE EXCELENCIA EN EPIGENETICA 52K€ Cerrado

MBG-BRIDGE STRENGTHENING THE RESEARCH CAPACITY OF BOGAZICI UNIVERSITY M... 1M€ Cerrado

Solve-RD Solving the unsolved Rare Diseases 15M€ Cerrado

E-Rare-3 ERA NET rare disease research implementing IRDiRC objectives 23M€ Cerrado

Líder del proyecto

INSTITUT ZA MOLEKULARNU GENETIKU I GENETICKO... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 2M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto SERBORDISinn will enable IMGGE to become the most recognizable molecular genetic (MG) centre in the Balkans. IMGGE is the leading Serbian MG research institution, employing scientists with the highest expertise in molecular biology and molecular genetics. Research in the field of biomedical science of rare diseases (RD) is a major interest of IMGGE’s Laboratory for Molecular Hematology, Laboratory for Molecular Biology, Laboratory for Human Molecular Genetics and Laboratory for Molecular Genetics of Industrial Microorganisms. EU partnering organizations and EU experts, well known for their excellence in the topics related to SERBORDISinn, will be actively involved in the realization of the Project. Consequently, exchange of expertise and experience related to RD would intensify the transfer of knowledge from distinguished EU centers to IMGGE, enabling the implementation of cutting-edge MG approaches for the study of molecular markers of RD. Furthermore, SERBORDISinn will reinforce the establishment of Serbian and Balkan RD-specific databases and biobanks. Building a strong network with medical institutions and adopting protocols for high quality sample handling will facilitate the integration of IMGGE into the European initiative to build a biobank network. State-of-the-art methodologies in biomedical studies and RD biobanks will set up the basis for functional studies of human mutations. This will enable the identification of potential targets, which, in collaboration with an SME, will lead to designing cost-effective diagnostic test kit(s), pushing IMGGE towards innovations, and paving the path to the application of genome-based medicine. The local network to be established, NIRBOS (Research Initiative for RD in Serbia or Naucna Inicijativa za Retke Bolesti u Srbiji, in Serbian), will facilitate the dissemination and exploitation of the SERBORDISinn results. NIRBOS will also provide long-term sustainability of the Project. The implementation of SERBORDISinn will have an impact on unlocking and developing IMGGE’s research and innovation potential, improving public health in Serbia, strengthening cooperation with local partners, as well as Balkan and EU research institutions. SERBORDISinn activities will lead to the establishment of a high proficiency expert centre for MG studies of RD in IMGGE and to the real integration of IMGGE into the ERA.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores